To this aim, we evaluated insulin-stimulated myocardial glucose metabolism using cardiac dynamic Myocardial positron emission tomography (PET) with 18F-Fluorodeoxyglucose (18F-FDG) combined with euglycemic-hyperinsulinemic clamp in T2DM individuals with or without MetS. Here, INS is linked to metabolic syndrome.